• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺间变性癌的预后因素——188例患者的多变量生存分析

Prognostic factors in anaplastic carcinoma of the thyroid-a multivariate survival analysis of 188 patients.

作者信息

Besic Nikola, Hocevar Marko, Zgajnar Janez, Pogacnik Ana, Grazio-Frkovic Snjezana, Auersperg Marija

机构信息

Department of Surgery, Institute of Oncology, Zaloska 2, 1000, Ljubljana, Slovenia.

出版信息

Langenbecks Arch Surg. 2005 Jun;390(3):203-8. doi: 10.1007/s00423-004-0524-5. Epub 2004 Dec 15.

DOI:10.1007/s00423-004-0524-5
PMID:15599758
Abstract

BACKGROUND

Multivariate studies concerning the prognosis of patients with anaplastic carcinoma of the thyroid gland are scarce. The aim of our study was to determine the prognostic factors associated with survival of patients with anaplastic carcinoma in Slovenia, an iodine-deficient region.

METHODS

This retrospective study was carried out on a group of 188 patients (130 female, 58 male; median age 68 years) with anaplastic carcinoma of the thyroid who had been treated at a tertiary care centre from 1972 to 2003. For each patient, data on gender, age, disease history, extent of disease, morphological characteristics, mode of therapy, and survival were collected. Statistical correlation between possible prognostic factors and survival was analysed by univariate and Cox's multivariate analysis. Treatment modality was not included in the analysis to avoid selection bias.

RESULTS

The median survival of all the patients was 3 (+/-0.36) months. Overall 1-year survival of our patients was 13%, and 2-year survival was 6%. Multivariate analysis showed that the patients' age, performance status, tumour growth, tumour extension and distant metastases were independent prognostic factors for the survival.

CONCLUSION

Patients younger than 71 years, with a good performance status and slowly growing tumours confined to the thyroid, and without distant metastases, had the best prognosis.

摘要

背景

关于甲状腺间变性癌患者预后的多因素研究较少。我们研究的目的是确定在碘缺乏地区斯洛文尼亚,与甲状腺间变性癌患者生存相关的预后因素。

方法

这项回顾性研究针对1972年至2003年在一家三级护理中心接受治疗的188例甲状腺间变性癌患者(130例女性,58例男性;中位年龄68岁)进行。收集了每位患者的性别、年龄、疾病史、疾病范围、形态学特征、治疗方式和生存数据。通过单因素分析和Cox多因素分析来分析可能的预后因素与生存之间的统计学相关性。分析中未纳入治疗方式以避免选择偏倚。

结果

所有患者的中位生存期为3(±0.36)个月。我们患者的总体1年生存率为13%,2年生存率为6%。多因素分析表明,患者的年龄、体能状态、肿瘤生长、肿瘤范围和远处转移是生存的独立预后因素。

结论

年龄小于71岁、体能状态良好、肿瘤生长缓慢且局限于甲状腺且无远处转移的患者预后最佳。

相似文献

1
Prognostic factors in anaplastic carcinoma of the thyroid-a multivariate survival analysis of 188 patients.甲状腺间变性癌的预后因素——188例患者的多变量生存分析
Langenbecks Arch Surg. 2005 Jun;390(3):203-8. doi: 10.1007/s00423-004-0524-5. Epub 2004 Dec 15.
2
Prognostic factors in follicular carcinoma of the thyroid--a multivariate survival analysis.
Eur J Surg Oncol. 1999 Dec;25(6):599-605. doi: 10.1053/ejso.1999.0714.
3
Prognostic factors for Korean patients with anaplastic thyroid carcinoma.韩国间变性甲状腺癌患者的预后因素。
Head Neck. 2007 Aug;29(8):765-72. doi: 10.1002/hed.20578.
4
Management and outcome of recurrent well-differentiated thyroid carcinoma.复发性高分化甲状腺癌的管理与预后
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819.
5
Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002.手术和放射治疗可提高间变性甲状腺癌患者的生存率:1983 - 2002年监测、流行病学及最终结果分析
Am J Clin Oncol. 2008 Oct;31(5):460-4. doi: 10.1097/COC.0b013e31816a61f3.
6
Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.完全切除的间变性甲状腺癌联合辅助化疗和放疗与生存期延长相关。
Cancer. 2001 Jun 15;91(12):2335-42.
7
Surgical treatment of anaplastic thyroid carcinoma. Our experience.间变性甲状腺癌的外科治疗。我们的经验。
G Chir. 2010 Jun-Jul;31(6-7):282-5.
8
[Anaplastic thyroid carcinoma: diagnosis, treatment and prognosis].
Vopr Onkol. 2007;53(1):37-45.
9
Effect of primary treatment on survival in anaplastic thyroid carcinoma.初次治疗对间变性甲状腺癌患者生存的影响。
Eur J Surg Oncol. 2001 Apr;27(3):260-4. doi: 10.1053/ejso.2000.1098.
10
Survival and prognostic factors of anaplastic thyroid carcinoma.间变性甲状腺癌的生存及预后因素
Acta Chir Belg. 2015 Jan-Feb;115:62-7.

引用本文的文献

1
A pancreatic metastasis of anaplastic thyroid carcinoma: a rare case report.间变性甲状腺癌胰腺转移:1例罕见病例报告
Ann Med Surg (Lond). 2023 Feb 7;85(2):228-230. doi: 10.1097/MS9.0000000000000179. eCollection 2023 Feb.
2
Prognostic Role of Pre-Treatment [F]FDG PET/CT in Patients with Anaplastic Thyroid Cancer.治疗前[F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在间变性甲状腺癌患者中的预后作用
Cancers (Basel). 2021 Aug 23;13(16):4228. doi: 10.3390/cancers13164228.
3
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.

本文引用的文献

1
The important role of operations in the management of anaplastic thyroid carcinoma.手术在间变性甲状腺癌管理中的重要作用。
Surgery. 2002 Mar;131(3):245-8. doi: 10.1067/msy.2002.119936.
2
The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma.
Ann Surg Oncol. 2002 Jan-Feb;9(1):57-64. doi: 10.1245/aso.2002.9.1.57.
3
Effect of primary treatment on survival in anaplastic thyroid carcinoma.初次治疗对间变性甲状腺癌患者生存的影响。
Eur J Surg Oncol. 2001 Apr;27(3):260-4. doi: 10.1053/ejso.2000.1098.
2021 年美国甲状腺协会甲状腺间变性癌患者管理指南。
Thyroid. 2021 Mar;31(3):337-386. doi: 10.1089/thy.2020.0944.
4
Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging.间变性甲状腺癌:WHO 分类、临床病理特征和分期的更新。
Histol Histopathol. 2021 Mar;36(3):239-248. doi: 10.14670/HH-18-277. Epub 2020 Nov 10.
5
Dietary iodine intake, therapy with radioiodine, and anaplastic thyroid carcinoma.碘的饮食摄入、放射性碘治疗与间变性甲状腺癌。
Radiol Oncol. 2020 May 2;54(2):187-193. doi: 10.2478/raon-2020-0023.
6
Combinatorial Therapies in Thyroid Cancer: An Overview of Preclinical and Clinical Progresses.甲状腺癌的联合治疗:临床前和临床进展概述。
Cells. 2020 Mar 30;9(4):830. doi: 10.3390/cells9040830.
7
Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma.间变性甲状腺癌第八版TNM分类评估
Cancers (Basel). 2020 Feb 27;12(3):552. doi: 10.3390/cancers12030552.
8
Nomograms Predict Survival in Patients with Anaplastic Thyroid Carcinoma.列线图预测间变性甲状腺癌患者的生存情况。
Med Sci Monit. 2019 Nov 9;25:8447-8456. doi: 10.12659/MSM.918245.
9
Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling.全面基因组分析鉴定出间变性甲状腺癌的独特突变模式。
Head Neck. 2019 Jun;41(6):1928-1934. doi: 10.1002/hed.25634. Epub 2019 Feb 13.
10
Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.放射治疗剂量与未切除的间变性甲状腺癌患者生存率提高相关:来自美国国立癌症数据库的结果
Cancer. 2017 May 1;123(9):1653-1661. doi: 10.1002/cncr.30493. Epub 2016 Dec 27.
4
Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid.甲状腺间变性癌的预后因素及治疗策略
World J Surg. 2001 May;25(5):617-22. doi: 10.1007/s002680020166.
5
Anaplastic thyroid carcinoma: current diagnosis and treatment.间变性甲状腺癌:当前的诊断与治疗
Ann Oncol. 2000 Sep;11(9):1083-9. doi: 10.1023/a:1008322002520.
6
Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis.间变性(未分化)甲状腺癌(ATC)。一项回顾性分析。
Langenbecks Arch Surg. 1999 Jun;384(3):284-93. doi: 10.1007/s004230050205.
7
Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.
Thyroid. 1998 Aug;8(8):715-26. doi: 10.1089/thy.1998.8.715.
8
Prognostic factors and risk group analysis in follicular carcinoma of the thyroid.甲状腺滤泡癌的预后因素及风险组分析
Surgery. 1995 Dec;118(6):1131-6; discussion 1136-8. doi: 10.1016/s0039-6060(05)80124-2.
9
Evaluation of survival data and two new rank order statistics arising in its consideration.生存数据的评估以及在考虑过程中出现的两个新的排序统计量。
Cancer Chemother Rep. 1966 Mar;50(3):163-70.
10
Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases.甲状腺间变性癌:82例临床病理研究
Mayo Clin Proc. 1985 Jan;60(1):51-8. doi: 10.1016/s0025-6196(12)65285-9.